Insulin, Insulin-like Growth Factor 1 and cancer
Insulin Potentiation Therapy (IPT) acknowledges the fact that cancer cells have approximately14 times more insulin receptor sites than healthy cells and so uses insulin to 'potentiate' very low doses of standard chemotherapy drugs into cancer cells. IPT is claimed to be a far less invasive than standard chemotherapy treatment. Because a cocktail of 5 or 6 chemotherapy drugs is normally used in IPT, practitioners believe it is more effective than standard chemotherapy. As you would expect, the therapy is highly criticised in orthodox medical circles but there are clinics in America, Germany and South East Asia who advocate IPT and there is even a Regulatory Body. At CANCERactive we have had a good number of patients who have used IPT as part of a successful anti-cancer programme.
